Dr. Reddy's Laboratories
RDY
#1702
Rank
C$17.53 B
Marketcap
C$21.04
Share price
2.62%
Change (1 day)
10.89%
Change (1 year)

EPS for Dr. Reddy's Laboratories (RDY)

EPS in 2023 (TTM): C$5.00

According to Dr. Reddy's Laboratories's latest financial reports the company's current EPS (TTM) is C$0.51. In 2022 the company made an earnings per share (EPS) of C$3.83 an increase over its 2021 EPS that were of C$3.24.

EPS history for Dr. Reddy's Laboratories from 2002 to 2023

Annual EPS

Year EPS Change
2023 (TTM)C$5.0030.72%
2022C$3.8318.14%
2021C$3.2434.07%
2020C$2.4221.36%
2019C$1.99-7.1%
2018C$2.1464.13%
2017C$1.317.5%
2016C$1.21-61.17%
2015C$3.135.97%
2014C$2.95-5.38%
2013C$3.1246.78%
2012C$2.12-13.09%
2011C$2.4441.17%
2010C$1.73-199.25%
2009C-$1.74-269.81%
2008C$1.03-12.82%
2007C$1.180.54%
2006C$1.17301.34%
2005C$0.2972.26%
2004C$0.17-68.7%
2003C$0.5425.18%
2002C$0.43

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Novartis
NVS
C$7.41 1,349.99%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
C$1.07 109.90%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
C$2.69 425.57%๐Ÿ‡ซ๐Ÿ‡ท France
GSK plc
GSK
C$4.06 694.69%๐Ÿ‡ฌ๐Ÿ‡ง UK
Teva Pharmaceutical Industries
TEVA
C$0.89 74.00%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel